This study is looking into how endometriosis and its treatments might affect your heart health. Researchers want to understand if suppressing estrogen, a common treatment for endometriosis, could impact blood vessel function. They will be testing a medication called Elagolix (400 mg/day oral, 2X200 mg tablets/day for 4 days) to see its effects. The study aims to measure changes in blood vessel function using tests like Flow Mediated Vasodilation and Microvascular skin blood flow analysis. You may be able to join if you are a woman between 18 and 45 years old, with or without endometriosis. The study is looking for 40 participants in total. The current recruitment status is unclear.

Study design

This interventional study plans to enroll 40 women between 18 and 45 years old, both with and without endometriosis.

What's involved

Participants will receive Elagolix for 4 days. Blood vessel function will be measured at 2 minutes and 15 minutes during the study.

Compensation

Not stated in the trial record.

Follow-up

Blood vessel function will be measured at 2 minutes and 15 minutes after certain procedures.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.